Deletion of the G2A receptor fails to attenuate experimental autoimmune encephalomyelitis (Q41880018)

13 October 2017

Deletion of the G2A receptor fails to attenuate experimental autoimmune encephalomyelitis (English)

1 reference

13 October 2017

Inga Osmers

1 reference

13 October 2017

Sherry S Smith

1 reference

13 October 2017

Brian W Parks

1 reference

13 October 2017

Shaohua Yu

1 reference

13 October 2017

Roshni Srivastava

1 reference

13 October 2017

Jillian E Wohler

1 reference

13 October 2017

Scott R Barnum

1 reference

13 October 2017

Janusz H S Kabarowski

1 reference

13 October 2017

9 January 2009

1 reference

Journal of Neuroimmunology

13 October 2017

1 reference

13 October 2017

207

1 reference

13 October 2017

1-2

1 reference

13 October 2017

18-23

1 reference

Disruption of the beta2-integrin CD11d (alphaDbeta2) gene fails to protect against experimental autoimmune encephalomyelitis

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692575

Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692575

Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692575

T cell chemotaxis to lysophosphatidylcholine through the G2A receptor.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692575

I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692575

Lysophospholipids and their G protein-coupled receptors in inflammation and immunity

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692575

Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692575

Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692575

Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692575

Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692575

Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient mice.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692575

Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2692575

Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19135725

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JNEUROIM.2008.11.008

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

19135725

1 reference